A postmarket surveillance study on electro-neuro-adaptive-regulator therapy

Rod P Bonello; Marc Cohen; John Reece; Arun Aggarwal; Curtis Rigney

doi:10.1155/2014/341256

A postmarket surveillance study on electro-neuro-adaptive-regulator therapy

Evid Based Complement Alternat Med. 2014:2014:341256. doi: 10.1155/2014/341256. Epub 2014 Jun 5.

Authors

Rod P Bonello¹, Marc Cohen², John Reece³, Arun Aggarwal⁴, Curtis Rigney⁵

Affiliations

¹ School of Health Professions, Murdoch University, Perth 6150, Australia.
² School of Health Sciences, RMIT University, Melbourne 3000, Australia.
³ School of Health Sciences, RMIT University, Melbourne 3000, Australia ; School of Psychological Science, Australian College of Applied Psychology, Sydney 2000, Australia.
⁴ University of Sydney, Sydney 2006, Australia.
⁵ Macquarie University, North Ryde 2109, Australia.

Abstract

The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for which the therapy was used and its perceived effectiveness are discussed. A web-based survey of Australian recipients of ENAR therapy was completed by 481 respondents. Most (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder, and neck pain; 8% used ENAR exclusively for nonmusculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% (t(423) = 38.73, P < .001) and functional improvement of 62% (t(423) = 10.45, P < .001) using 11-point numerical rating scales. Following ENAR treatment, medication reduction was reported by 91% of respondents. Most respondents reported high satisfaction following ENAR therapy, with between 15 and 20% achieving complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction.